APP and Alzheimer disease: In vitro experiments have shown that ginsenoside Rk3 modulates the AMPK signaling pathway and thus inhibits Aβ-induced apoptosis and ROS production, and in vivo experiments showed that ginsenoside Rk3 improved spatial learning and reduces AD pathology in APP/PS1 mice [161].